Not yet recruiting
Granulomatosis with polyangiitis+1
Not yet recruitingRituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)
Registered drugNo placebo
Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)
Registered drugNo placebo
- Disease:Granulomatosis with polyangiitisMicroscopic polyangiitis
- Substances:–
Countries:
France
France- Participants:18–64 years · 65+ years
- Sponsor:Assistance Publique Hopitaux De Paris





